Q32 Bio Inc. beat EPS estimates 50% of the time across 2 reported quarters (1 beats, 1 misses), averaging +6.6% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q2 FY26 | $-0.53 | $-0.44 | +17.0% | Beat | |
| Q1 FY26 | $-0.52 | $-0.54 | -3.9% | Miss | |
| Q4 FY25 | not reported | $3.65 | not reported | not reported |
Back to QTTB overview · QTTB holders · QTTB KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.